Biopharmaceutical manufacturing is ...
Biopharmaceutical manufacturing is getting a boost as several firms lately announced plans for new plants and research center as well as improvements to existing facilities. Berlex, the US affiliate of Schering AG Germany, is purchasing a 16-acre site for a $60 million biopharmaceutical plant near Lynwood WA. The of the present day manufacturing supply center will initially wait on to increase the supply of Leukine (sargramostim), a hematopoietic germination factor used in cancer care and in a less degree than investigation as a treatment for Crohn's disease. Akzo Nobel chose Cambridge as the what is yet to be site of an ...
|